iShares U.S. Healthcare ETF (IYH) Technical Analysis
$64.48
Market is closed - opens 7 PM, 15 Jun 2026
Insights
- U.S. Healthcare ETF iShares is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for U.S. Healthcare ETF iShares stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, U.S. Healthcare ETF iShares stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for U.S. Healthcare ETF iShares stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 61.82 | Sell |
Stochastic | 87.92, 86.28 | Neutral |
Ultimate Oscillator | 48.0 | Neutral |
Stochastic Relative Strength Index | 80.59, 86.52 | Sell |
Moving Average Convergence Divergence | 0.73, 0.52 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 63.5 | Buy |
20 | 62.82 | Buy |
50 | 62.01 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 63.74 | Buy |
20 | 63.07 | Buy |
50 | 62.59 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 63.84 | Neutral |
20 | 63.37 | Neutral |
50 | 62.61 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 64.52 | Buy |
20 | 63.99 | Buy |
50 | 62.43 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 64.71 | Buy |
20 | 64.57 | Buy |
50 | 63.24 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 65.71 |
Resistance L2 | 65.38 |
Resistance L1 | 64.74 |
Pivot Point | 64.41 |
Support L1 | 63.77 |
Support L2 | 63.44 |
Support L3 | 62.8 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.